Earnings History Data for Intersect ENT, Inc. (XENT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Intersect ENT, Inc.

Intersect ENT, Inc. is a commercial drug-device company. The Company's initial products, PROPEL and PROPEL mini, are drug-eluting implants for use in patients with chronic sinusitis. It offers products and therapies for ear, nose, and throat surgeons to improve treatment for their patients with chronic diseases. Intersect ENT, Inc. is headquartered in Menlo Park, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
02-11-2021	AH	After the close (Nov 2)	XENT	Intersect ENT, Inc.	901.68	-0.48	-0.42	-0.34	Intersect ENT EPS misses by $0.06, misses on revenue [11/2/2021 4:56 PM]	27.07	-0.09 (-0.33%)	27.15	-0.01 (-0.04%)	15.92 - 28.17	161,933	240,000	417
Intersect ENT EPS misses by $0.06, misses on revenue [11/2/2021 4:56 PM] Intersect ENT gets second request from FTC for planned sale to Medtronic (update) [11/3/2021 9:41 AM] Intersect ENT Reports Third Quarter 2021 Financial Results [Nov-02-21 04:15PM] Intersect ENT (XENT) Reports Q3 Loss, Lags Revenue Estimates [Nov-02-21 06:45PM] Intersect ENT (XENT) Q3 Loss Widens, Sell-Off Process On Track [Nov-03-21 11:07AM]
06-08-2021	PM	7:00 AM ET (Aug 6)	XENT	Intersect ENT, Inc.	773.83	-0.49	-0.42	-0.65	Intersect ENT EPS misses by $0.22, misses on revenue [8/6/2021 7:18 AM]	27.38	2.86 (11.66%)	27.70	3.18 (12.97%)	14.68 - 27.80	13,615,529	750,000	457,817
Intersect ENT EPS misses by $0.22, misses on revenue [8/6/2021 7:18 AM] Medtronic to acquire implant manufacturer Intersect ENT for $1.1 billion [8/6/2021 7:19 AM] Medtronic to Acquire Intersect ENT [Aug-06-21 07:00AM] Intersect ENT Reports Second Quarter 2021 Financial Results [Aug-06-21 07:15AM] UPDATE 1-Medtronic to buy Intersect ENT for $936 million [Aug-06-21 07:32AM] UPDATE 2-Medtronic snaps up Intersect ENT for $936 mln to bolster sinus portfolio [Aug-06-21 07:32AM] Intersect ENT (XENT) Reports Q2 Loss, Tops Revenue Estimates [Aug-06-21 08:35AM] Intersect ENT Stock Soars on Medtronic Acquisition [Aug-06-21 07:30AM] Shareholder Alert: Ademi LLP investigates whether Intersect ENT, Inc. has obtained a Fair Price in its transaction with Medtronic [Aug-06-21 12:12PM] Five Top Stock Gainers for Friday: Yelp, Switch, Intersect ENT [Aug-06-21 08:09AM] Intersect ENT Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Intersect ENT, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm XENT [Aug-06-21 12:45PM] INTERSECT ENT ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of XENT and Encourages Investors to Contact the Firm [Aug-06-21 01:23PM] SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Intersect ENT, Inc. Buyout [Aug-06-21 01:59PM] INTERSECT ENT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intersect ENT - XENT [Aug-06-21 06:41PM] SHAREHOLDER ALERT: WeissLaw LLP Investigates Intersect ENT, Inc. [Aug-06-21 04:31PM] Why Intersect ENT Shot 12% Higher on Friday [Aug-06-21 04:22PM]
10-05-2021	PM	7:00 AM ET (May 10)	XENT	Intersect ENT, Inc.	746.88	-0.51	-0.42	-0.54	Intersect ENT EPS misses by $0.08, beats on revenue; raises outlook [5/10/2021 7:07 AM]	18.22	-2.82 (-13.40%)	21.04	0.0 (0.00%)	10.84 - 26.98	271,675	190,000	1,105
Intersect ENT EPS misses by $0.08, beats on revenue; raises outlook [5/10/2021 7:07 AM] Intersect ENT to Participate at Upcoming Investor Conferences [May-07-21 04:05PM] Intersect ENT, Inc. to Host Earnings Call [May-10-21 06:45AM] Intersect ENT Reports First Quarter 2021 Financial Results [May-10-21 07:00AM] What's in Store for Intersect ENT's (XENT) Q1 Earnings? [May-10-21 07:36AM] Intersect ENT (XENT) Reports Q1 Loss, Tops Revenue Estimates [May-10-21 08:20AM]
09-03-2021	PM	7:00 AM ET (Mar 9)	XENT	Intersect ENT, Inc.	779.37	-0.54	-0.31	-0.25	Intersect ENT EPS misses by $0.22, beats on revenue [3/9/2021 7:06 AM]	22.26	-0.92 (-3.99%)	23.18	0.0 (0.00%)	5.97 - 26.98	209,160	259,027	6,601
Intersect ENT Q4 2020 Earnings Preview [3/8/2021 1:36 PM] Intersect ENT EPS misses by $0.22, beats on revenue [3/9/2021 7:06 AM] Intersect ENT Reports Fourth Quarter and Full Year 2020 Financial Results [Mar-09-21 07:00AM] Intersect ENT, Inc. to Host Earnings Call [Mar-09-21 05:30AM] A Preview Of Intersect ENT's Earnings [Mar-08-21 10:09AM] CMS Consolidates SINUVA Sinus Implant Coverage Under a Distinct Code, J7402, and Publishes an ASP Clarifying Payment and Easing Payer Coverage Adjudication [Mar-08-21 07:00AM] Intersect ENT (XENT) Reports Q4 Loss, Tops Revenue Estimates [Mar-09-21 08:35AM]
02-11-2020	PM	7:00 AM ET (Nov 2)	XENT	Intersect ENT, Inc.	510.15	-0.34	-0.44	-0.41	Intersect ENT EPS beats by $0.10, beats on revenue [11/2/2020 7:06 AM]	15.94	0.44 (2.87%)	15.50	0.0 (0.00%)	5.97 - 31.46	170,875	213,363	4,059

04-08-2020	PM	4:05 PM ET (Aug 4)	XENT	Intersect ENT, Inc.	559.69	-0.65	-0.56	-0.36	Intersect ENT EPS misses by $0.09, beats on revenue [8/4/2020 7:06 AM]	18.02	1.60 (9.74%)	17.00	0.58 (3.53%)	5.97 - 31.46	481,883	288,775	12,047